AARTI DRUGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 404.80 INR | -2.61% |
|
-4.62% | -12.12% |
| Feb. 03 | Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine | RE |
| Jan. 30 | Aarti Drugs Limited, Q3 2025 Earnings Call, Jan 30, 2025 |
Chart calendar Aarti Drugs Limited
71f12f0e2f1c.i7tYWfm5LtF7jjemaSWvX6yanGS-yyIh2Gf6FJ-boVk.5doSN5CIROcd3VXuLhb7EZT8-0mH_RpNuRGZR_Pcky74_mBtqfhLgA29XA~719727a60955f01698a5e3b1e5c52787
Upcoming events on Aarti Drugs Limited
Past events on Aarti Drugs Limited
| 2025-02-03 | Détachement de for dividende intermédiaire |
| 2025-01-30 12:30 am | Q3 2025 Earnings Call |
| 2025-01-29 06:11 am | Q3 2025 Earnings Release |
| 2024-11-27 11:30 pm | J P Morgan India Midcap Conference |
| 2024-11-18 03:30 am | Anand Rathi Flagship G-200 Conference |
| 2024-10-25 01:30 am | Q2 2025 Earnings Call |
| 2024-10-24 08:34 am | Q2 2025 Earnings Release |
| 2024-09-20 01:30 am | Annual General Meeting |
| 2024-09-18 12:30 am | Dolat Capital BFSI Conference |
| 2024-09-04 12:30 am | Ashwamedh Elara India Dialogue Conference |
| 2024-07-29 01:30 am | Q1 2025 Earnings Call |
| 2024-07-26 08:04 am | Q1 2025 Earnings Release |
| 2024-05-29 12:30 am | B&K Securities Trinity Investor Conference |
| 2024-05-06 01:30 am | Q4 2024 Earnings Call |
| 2024-05-03 07:07 am | Q4 2024 Earnings Release |
| 2024-03-28 01:30 am | Arihant Capital Bharat Connect Conference |
| 2024-02-05 | Détachement de for dividende intermédiaire |
| 2024-01-25 01:30 am | Q3 2024 Earnings Call |
| 2024-01-24 05:32 am | Q3 2024 Earnings Release |
| 2023-11-07 11:30 pm | Anand Rathi Flagship G-200 Conference |
Past dividends on Aarti Drugs Limited
| 2025-02-03 | Interim Payment 1 INR |
| 2024-02-05 | Interim Payment 1 INR |
| 2023-02-07 | Interim Payment 1 INR |
| 2022-02-08 | Interim Payment 1 INR |
| 2020-11-02 | Interim Payment 2.5 INR |
| 2020-02-16 | Interim Payment 2 INR |
| 2019-07-25 | Annual 1 INR |
| 2018-07-31 | Annual 1 INR |
| 2017-08-08 | Annual 1 INR |
| 2016-03-21 | Interim Payment 3 INR |
| 2016-02-11 | Interim Payment 1.5 INR |
| 2015-11-09 | Interim Payment 2.25 INR |
| 2015-08-04 | Final Payment 3 INR |
| 2015-02-03 | Interim Payment 5 INR |
| 2014-11-18 | Interim Payment 5 INR |
| 2014-07-01 | Final Payment 5.5 INR |
| 2014-02-04 | Interim Payment 4.5 INR |
| 2013-11-18 | Interim Payment 3 INR |
| 2013-07-23 | Final Payment 4 INR |
| 2013-02-10 | Interim Payment 3 INR |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 24 887 24 552 1.36% | 27 161 26 590 2.15% | 25 286 26 118 -3.19% | 23 031 | 26 804 | 30 456 |
|
EBITDA Million INR | Released Forecast Spread | 3 294 3 478 -5.28% | 3 056 3 027 0.97% | 3 165 3 186 -0.67% | 2 626 | 3 592 | 4 416 |
|
EBIT Million INR | Released Forecast Spread | 2 794 2 978 -6.18% | 2 553 2 438 4.71% | 2 650 2 583 2.6% | 2 078 | 2 983 | 3 755 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 700 2 877 -6.17% | 2 242 2 168 3.42% | 2 355 2 306 2.14% | 1 883 | 2 689 | 3 474 |
|
Net income Million INR | Released Forecast Spread | 2 050 2 170 -5.51% | 1 663 1 633 1.84% | 1 714 1 730 -0.91% | 1 412 | 2 017 | 2 606 |
|
EPS INR | Released Forecast Spread | 22,1 23,3 -5.06% | 18,0 17,6 1.91% | 18,6 18,7 -0.75% | 15,5 | 22,1 | 28,5 |
| Announcement Date | 09/05/22 | 29/04/23 | 03/05/24 | - |
Quarterly results
| Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 6 877 6 374 7.9% | 6 640 7 300 -9.05% | 7 424 7 082 4.83% | 6 611 7 011 -5.7% |
|
EBITDA Million INR | Released Forecast Spread | 743 761 -2.4% | |||
|
Net income Million INR | Released Forecast Spread | 388 388 -0.13% | |||
| Announcement Date | 20/10/22 | 27/01/23 | 29/04/23 | 21/07/23 |
| 2025-02-10 | ROYALTY PHARMA PLC: Q4 2024 Earnings Release |
| 2025-02-10 | LUPIN LIMITED: Q3 2025 Earnings Release |
| 2025-02-10 | MARKSANS PHARMA LIMITED: Q3 2025 Earnings Release |
| 2025-02-10 | ASTRAZENECA PHARMA INDIA LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 04:02 pm | GILEAD SCIENCES, INC.: Q4 2024 Earnings Release |
| 2025-02-11 | CORCEPT THERAPEUTICS INCORPORATED: Q4 2024 Earnings Release (Projected) |
| 2025-02-11 | NATCO PHARMA LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 | SUVEN PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 | ROHTO PHARMACEUTICAL CO.,LTD.: Q3 2024 Earnings Release |
| 2025-02-11 | ORCHID PHARMA LIMITED: Q3 2025 Earnings Release |
Past sector events for Aarti Drugs Limited
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
- Calendar Aarti Drugs Limited